Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology.
Methods: Forty participants from nine countries participated.
Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed.
Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.
Keywords: OMERACT; OUTCOME ASSESSMENT (HEALTHCARE); RHEUMATIC DISEASES; TREATMENT ADHERENCE AND COMPLIANCE.